Drug Resistance and Newly-Funded Research
by Amy C. Moore, PhD, Director, Science & Research, GO2 for Lung Cancer Patients with lung cancer face the challenge of drug resistance, while researchers focus on extending treatment duration. In collaboration with the patient group ALK Positive, we [...]